Pharma Marketing May Contribute to Stimulant Oversupply
Amid widespread prescription stimulant misuse, new research begins to characterize how pharmaceutical marketing may play a role.
Read MoreWhy Do People Who Inject Drugs Delay Treatment for Infections?
Understanding the reasons for self-treatment and targeting community settings may help providers reach people who avoid necessary care, a new study suggests.
Read MoreFor Hospitals, A Blueprint for Fighting the Opioid Epidemic
A new report from the Grayken Center for Addiction and the Institute for Healthcare Improvement collects evidence-based strategies to help hospitals fight the opioid epidemic.
Read MoreInfectious Disease Physicians Need a New Subspecialty: Addiction
Experts call for integrated subspecialty training that acknowledges the relationship between addiction and infectious disease.
Read MoreLow-Barrier Treatment for SUD Key for Engagement and Retention
Boston Public Health Commission’s Devin Larkin explains that how services are delivered matters for engagement and retention in treatment for substance use disorder.
Read MoreEven After Overdose, Only 1 in 3 Young Adults Receive OUD Meds
Research highlights opportunity to intervene with adolescents, a group who’s particularly vulnerable to addiction and overdose.
Read More‘Meth Is Here and Now’: A Growing Presence in the Opioid Crisis
An HIV and addiction expert shares his insights into the evolving presence of methamphetamine in the opioid crisis and its implications for curbing substance use disorder.
Read MoreWe Need to Think Bigger Than Opioid Stewardship
To tackle the overdose epidemic, focusing on opioid prescriptions alone is not enough. New research shows that we’re missing opportunities to save thousands of lives.
Read MoreNew Remote Dispensing Naloxone Policy Will Increase Access
Pharmacy pickup is a significant barrier to naloxone access. A policy allows pharmacists to hand out the drug directly at the point of care.
Read MoreJournalist Maia Szalavitz on Addiction as a Learning Disorder
The author of Unbroken Brain discusses our evolving understanding of addiction — and the implications for how we treat and prevent substance use disorders.
Read MoreContinued Naltrexone Use for OUD May Be Favorable in Pregnancy
New findings suggest that the understudied medication naltrexone may lead to better short-term outcomes for some pregnant women with OUD and their babies.
Read MoreResearchers Explore Overdose Risk Factors in Teens, Young Adults
Polysubstance use, psychiatric conditions, witnessing an overdose, and a lack of stable housing stand out as risk factors among people age 30 and under.
Read More